Dana Aftab - 27 Feb 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
CSO/EVP Disc & Trans Research
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
27 Feb 2023
Net transactions value
-$227,700
Form type
4
Filing time
01 Mar 2023, 18:56:44 UTC
Previous filing
17 Feb 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $147 +10 +0% $14.74 351,482 27 Feb 2023 Direct F1
transaction EXEL Common Stock Sale $175 -10 -0% $17.50 351,472 27 Feb 2023 Direct
transaction EXEL Common Stock Options Exercise $1,215,903 +82,490 +23% $14.74 433,962 28 Feb 2023 Direct
transaction EXEL Common Stock Sale $1,443,575 -82,490 -19% $17.50 351,472 28 Feb 2023 Direct F2
holding EXEL Common Stock 5,835 27 Feb 2023 By 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -10 -0.01% $0.000000 82,490 27 Feb 2023 Common Stock 10 $14.74 Direct
transaction EXEL Option (right to buy) Options Exercise $0 -82,490 -100% $0.000000* 0 28 Feb 2023 Common Stock 82,490 $14.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 210,090 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.50 to $17.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 27, 2023.